GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia

…, A Bermúdez, J Pardo, C Amado, A Insunza… - MedRxiv, 2020 - medrxiv.org
Background We aimed to determine whether a 6-day course of intravenous methylprednisolone
(MP) improves outcome in patients with SARS CoV-2 infection at risk of developing …

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

…, J Bargay, J Petit, J De La Serna, A Insunza… - …, 2002 - Wiley Online Library
BACKGROUND: Predictive factors of the response to rHuG–CSF in normal donors have not
been extensively studied. STUDY DESIGN AND METHODS: We analyzed factors …

[HTML][HTML] Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the …

…, C Arbona, MJ Pascual, C Zamora, A Insunza… - …, 2008 - haematologica.org
Background Information about the long-term follow-up and safety of granulocyte colony-stimulating
factor administration to healthy donors is limited. The aims of this study were to …

[HTML][HTML] Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis

…, D Suárez-Vilela, R Benito, M Fuertes, A Insunza… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The biological and molecular events that underlie bone marrow fibrosis in patients with
myelodysplastic syndromes are poorly understood, and its prognostic role in the era of the …

[HTML][HTML] Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q

…, I Oliver, F Carbonell, E Bureo, A Insunza… - …, 2008 - haematologica.org
Background More than 50% of patients with myelodysplastic syndromes present cytogenetic
aberrations at diagnosis. Partial or complete deletion of the long arm of chromosome 5 is …

Tandem transplants with different high‐dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Espanol de Sindromes …

…, S Larregla, E Conde, A Insunza… - British journal of …, 2003 - Wiley Online Library
Between 1994 and 1999, 88 multiple myeloma (MM) patients were included in a phase II
study to evaluate a tandem autologous stem cell transplantation (ASCT) programme. The first …

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

…, R Collado, T Bernal, C Pedro, A Insunza… - Annals of …, 2021 - Springer
SF3B1 is a highly mutated gene in myelodysplastic syndrome (MDS) patients, related to a
specific subtype and parameters of good prognosis in MDS without excess blasts. More than …

The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage …

…, C Richard, JC Segovia, A Insunza… - Blood, The Journal …, 1997 - ashpublications.org
Expression of the apoptosis inhibitory protein Bcl-x was studied in CD34 + hematopoietic
precursor cells and in the promyelocytic leukemia cell line HL-60. The enriched population of …

Simultaneous cytomorphologic and multiparametric flow cytometric analysis on lymph node samples is faster than and as valid as histopathologic study to diagnose …

M Colorado, MA Cuadrado, A Insunza… - American journal of …, 2010 - academic.oup.com
We evaluated the validity and accuracy of cytomorphology and multiparametric flow cytometry
(C-FCM) in diagnosing oncohematologic disease in 223 consecutive lymph node biopsy …

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral …

…, N Puig, E Barragán, R de Paz, C Pedro, A Insunza… - Annals of …, 2012 - Springer
Several studies have evaluated the prognostic value of the individual expression of certain
genes in patients with myelodysplastic syndromes (MDS). However, none of them includes …